801
Views
11
CrossRef citations to date
0
Altmetric
REVIEW

Advances and Prospects in the Treatment of Pancreatic Cancer

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3973-3988 | Received 21 Mar 2023, Accepted 11 Jul 2023, Published online: 19 Jul 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mingjie Wang, Wenxiang Xue, Hanghang Yuan, Zhicheng Wang & Lei Yu. (2024) Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer. International Journal of Nanomedicine 19, pages 2823-2849.
Read now
Zhaohui Chen, Pengbiao Miao, Hongcao Lin & Yanan Lu. (2024) AHNAK2 Promotes the Progression of Pancreatic Ductal Adenocarcinoma by Maintaining the Stability of c-MET. Cancer Management and Research 16, pages 431-444.
Read now

Articles from other publishers (9)

Xu Luo, Zhengchen Ye, Chenglei Xu, Huan Chen, Shupeng Dai, Weihong Chen & Guoqing Bao. (2024) Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway. Molecular Biology Reports 51:1.
Crossref
Boyu Qin, Qi Xiong, Lingli Xin, Ke Li, Weiwei Shi, Qi Song, Qiong Sun, Jiakang Shao, Jing Zhang, Xiao Zhao, Jinyu Liu, Jinliang Wang & Bo Yang. (2024) Synergistic effect of additional anlotinib and immunotherapy as second‐line or later‐line treatment in pancreatic cancer: A retrospective cohort study. Cancer Innovation 3:4.
Crossref
Andreea Nedelcu, Teodora Mocan, Lavinia Ioana Sabau, Cristian Tudor Matea, Flaviu Tabaran, Teodora Pop, Cristian Delcea, Ofelia Mosteanu & Lucian Mocan. (2024) In vitro photothermal therapy of pancreatic cancer mediated by immunoglobulin G-functionalized silver nanoparticles. Scientific Reports 14:1.
Crossref
Guo-Hua Liu, Xiao-Yu Tan, Zhen-Yue Xu, Jia-Xing Li, Guo-Hui Zhong, Jing-Wei Zhai & Ming-Yi Li. (2024) REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer. Scientific Reports 14:1.
Crossref
Ke Zhang, Jie Zhu, Peng Wang, Yuan Chen, Zhengwang Wang, Xinyu Ge, Junqing Wu, Long Chen, Yipin Lu, Peng Xu & Jie Yao. (2024) Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization. Frontiers in Immunology 15.
Crossref
Mohana Chakkera, Jeremy B. Foote, Batoul Farran & Ganji Purnachandra Nagaraju. (2024) Breaking the stromal barrier in pancreatic cancer: Advances and challenges. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879:1, pages 189065.
Crossref
Peng Cheng, Shuai Ming, Wei Cao, Jixiao Wu, Qiwei Tian, Jing Zhu & Wei Wei. (2024) Recent advances in sonodynamic therapy strategies for pancreatic cancer. WIREs Nanomedicine and Nanobiotechnology 16:1.
Crossref
Jie Liu, Xinyu Gu, Zhenjie Guan, Di Huang, Huiwu Xing & Lian Zheng. (2023) Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer. Journal of Translational Medicine 21:1.
Crossref
A-Rum Yoon, JinWoo Hong, Bo-Kyeong Jung, Hyo Min Ahn, Songnam Zhang & Chae-Ok Yun. (2023) Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?. Cancer Letters 579, pages 216456.
Crossref